Research Article
Promoter Hypermethylation of the EMP3 Gene in a Series of 229 Human Gliomas
Table 1
Patient demographics.
| Tumor type | WHO grading | Patients (n) | Gender (M/F) | Mean age (years) and range |
| Pilocytic astrocytoma | I | 23 | 14/9 | 36 (9–68) | Diffuse and gemistocytic astrocytoma | II | 14 | 6/8 | 41 (13–68) | Anaplastic astrocytoma | III | 9 | 6/3 | 55 (38–78) | Primary GBM | IV | 68 | 45/23 | 63 (27–81) | Secondary GBM | IV | 3 | 3/0 | 45 (42–50) | Oligoastrocytoma | II | 12 | 9/3 | 42 (31–63) | Anaplastic oligoastrocytoma | III | 8 | 4/4 | 52 (37–71) | Oligodendroglioma | II | 54 | 29/25 | 47 (26–79) | Anaplastic oligodendroglioma | III | 38 | 23/15 | 55 (31–80) |
|
|